41 related articles for article (PubMed ID: 17198786)
1. Therapeutic Targeting of DNA Replication Stress in Cancer.
Gu L; Hickey RJ; Malkas LH
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510250
[TBL] [Abstract][Full Text] [Related]
2. The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA.
Gu L; Lingeman R; Yakushijin F; Sun E; Cui Q; Chao J; Hu W; Li H; Hickey RJ; Stark JM; Yuan YC; Chen Y; Vonderfecht SL; Synold TW; Shi Y; Reckamp KL; Horne D; Malkas LH
Clin Cancer Res; 2018 Dec; 24(23):6053-6065. PubMed ID: 29967249
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Wang X; Hickey RJ; Malkas LH; Koch MO; Li L; Zhang S; Sandusky GE; Grignon DJ; Eble JN; Cheng L
Prostate; 2011 May; 71(7):748-54. PubMed ID: 21031434
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarrays in clinical oncology.
Voduc D; Kenney C; Nielsen TO
Semin Radiat Oncol; 2008 Apr; 18(2):89-97. PubMed ID: 18314063
[TBL] [Abstract][Full Text] [Related]
5. Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China.
Huang B; Hu B; Su M; Tian D; Guo Y; Lian S; Liu Z; Wu X; Li Q; Zheng R; Gao Y
Hum Pathol; 2011 Jun; 42(6):808-16. PubMed ID: 21237484
[TBL] [Abstract][Full Text] [Related]
6. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
7. Barrett's oesophagus: mucin composition, neuroendocrine cells, p53 protein, cellular proliferation and differentiation.
Jaskiewicz K; Louw J; Anichkov N
Anticancer Res; 1994; 14(5A):1907-12. PubMed ID: 7847825
[TBL] [Abstract][Full Text] [Related]
8. An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia.
Lu D; Vohra P; Chu PG; Woda B; Rock KL; Jiang Z
Am J Surg Pathol; 2009 Apr; 33(4):521-5. PubMed ID: 19047899
[TBL] [Abstract][Full Text] [Related]
9. Assessment of proliferating cell nuclear antigen expression in dysplastic intestinal type Barrett's esophagus. Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
Lapertosa G; Baracchini P; Fulcheri E
Pathologica; 1994 Apr; 86(2):174-9. PubMed ID: 7936762
[TBL] [Abstract][Full Text] [Related]
10. A novel biomarker for the detection of esophageal adenocarcinoma.
Hammoud ZT; Badve S; Saxena R; Kesler KA; Rieger K; Malkas LH; Hickey RJ
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):82-7. PubMed ID: 17198786
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]